✦ LIBER ✦

Toxicity of Dose-Dense Docetaxel Followed by Doxorubicin with Cyclophosphamide as Adjuvant Therapy for Breast Cancer in a Phase II Study

✍ Scribed by Rosemary Lambert-Falls; Susan Modugno

Book ID: 115075747
Publisher: CIG Media Group, LP.
Year: 2007
Tongue: English
Weight: 110 KB
Volume: 7
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2007.n.029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A dose-dense schedule of docetaxel follo

A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study

✍ Silvia Antolín; Ramón Mel; Manuel Ramos; Andrés García-Palomo; Concepción Almanz 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 118 KB

Doxorubicin/Pemetrexed Followed by Docet

Doxorubicin/Pemetrexed Followed by Docetaxel Versus Doxorubicin/Cyclophosphamide Followed by Docetaxel as Neoadjuvant Treatment for Early-Stage Breast Cancer: A Randomized Phase II Trial

✍ Andreas Schneeweiss; Ilka Lauschner; Amparo Ruiz; Angel Guerrero; Pedro Sánchez- 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 88 KB

A Phase II Study of Sequential Docetaxel

A Phase II Study of Sequential Docetaxel Followed by Doxorubicin/Cyclophosphamide as First-Line Chemotherapy For Metastatic Breast Cancer

✍ Antonio Antón; Javier Hornedo; Ana Lluch; Bartomeu Massuti; Mónica Corral; Ramon 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 110 KB

Phase III Trial Comparing Doxorubicin Pl

Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer

✍ Jones, S. E.; Savin, M. A.; Holmes, F. A.; O'Shaughnessy, J. A.; Blum, J. L.; Vu 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 372 KB

Phase II Study of Neoadjuvant Docetaxel/

Phase II Study of Neoadjuvant Docetaxel/Vinorelbine Followed by Surgery and Adjuvant Doxorubicin/Cyclophosphamide in Women with Stage II/III Breast Cancer

✍ Steven A. Limentani; Adam M. Brufsky; John K. Erban; Mohammed Jahanzeb; Deborah 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 490 KB

A Phase II Feasibility Trial of Dose-Den

A Phase II Feasibility Trial of Dose-Dense Docetaxel Followed by Doxorubicin/Cyclophosphamide as Adjuvant or Neoadjuvant Treatment for Women with Node-Positive or High-Risk Node-Negative Breast Cancer

✍ Denise A. Yardley; Howard A. Burris III; Cindy P. Farley; John H. Barton; Nancy 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 109 KB